HomeHOSPITALSU.S. News & World Report Names Tampa General Hospital as Best in Tampa Bay

U.S. News & World Report Names Tampa General Hospital as Best in Tampa Bay

Tampa General Hospital is once again ranked as the #1 hospital in Tampa Bay by U.S. News & World Report for 2021-2022.

This is the sixth consecutive year that Tampa General has been named by U.S. News & World Report as Tampa Bay’s top hospital. Tampa General is also listed among the top four hospitals in Florida and ranked as one of the nation’s top 50 hospitals in five medical specialties, according to the digital media company.

The annual Best Hospitals rankings and ratings, now in their 32nd year, are designed to help patients and their doctors in making informed decisions about where to receive care for challenging health conditions or for common elective procedures. The high U.S. News rankings are a sign of Tampa General’s ability to treat the most complex illnesses and conditions, said TGH President and CEO John Couris.

“Year after year, Tampa General has been recognized as a leading healthcare system by U.S. News & World Report, considered by healthcare consumers as the global leader in quality rankings. Consistency in performance is what is most important as we continue on our journey to become the safest and most innovative academic health system in America,” Couris said. “I’m incredibly proud of our physicians and team members who deliver world-class care to our patients every day. Their dedication and commitment is the reason that Tampa General ranks so highly.”

Tampa General, the primary teaching hospital of the USF Health Morsani College of Medicine and one of the nation’s largest hospitals, is the leading academic medical center on the West Coast of Florida. It is known for performing the most challenging procedures and treating the most complex illnesses.

Tampa General is ranked as one of the nation’s 50 top hospitals, as well as the top hospital in Florida, in these five medical specialties:

  • Ear, Nose & Throat – ranked #21 in U.S. and #1 in Florida
  • Orthopedics – ranked #23 in U.S. and #1 in Florida
  • Gastroenterology & GI Surgery – ranked #26 in U.S. and tied for #1 in Florida
  • Diabetes & Endocrinology – ranked #28 in U.S. and #1 in Florida
  • Rehabilitation – ranked #36 in U.S. and tied for #1 in Florida

Tampa General also ranks as “high performing,” or among the top 10% of U.S. hospitals, in four more specialties:

  • Cancer
  • Geriatrics
  •  Neurology & Neurosurgery
  • Pulmonology & Lung Surgery

Finally, Tampa General also ranks as “high performing” in 12 procedures and conditions that include: Abdominal Aortic Aneurysm Repair, Acute Kidney Failure, COPD, Diabetes, Heart Attack, Heart Bypass Surgery, Heart Failure, Hip Replacement, Knee Replacement, Pneumonia, Spinal Fusion and Stroke.

For the 2021-22 rankings and ratings, U.S. News evaluated more than 4,750 medical centers nationwide in 15 specialties and 17 procedures and conditions. In the 15 specialty areas, 175 hospitals were ranked in at least one specialty. In rankings by state and metro area, U.S. News recognized hospitals as “high performing” across multiple areas of care.

“This year’s expanded report from U.S. News includes new ratings for important procedures and conditions to help each patient pick the right hospital for the type of care they need,” said Ben Harder, managing editor and chief of health analysis at U.S. News. “Hospitals faced incredible challenges this past year, and the best of them have provided great care throughout the pandemic and continue to offer excellent care today.”

The U.S. News Best Hospitals methodologies in most areas of care are based largely on objective measures such as risk-adjusted survival and discharge-to-home rates, volume, and quality of nursing, among other care-related indicators. Best Hospitals was produced by U.S. News with RTI International, a leading research organization based in Research Triangle Park, N.C.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected


Don't Miss

Mark Foster Joins Xenocor BOD

Foster is a versatile and visionary C-Suite executive who brings 20 years of general management and leadership experience from both venture-backed growth-stage organizations and world-class medical device companies

Hinge Health Acquires the Most Advanced Computer Vision Technology for Tracking Human Motion

CEO Daniel Perez explained, “We won’t stop investing in technology to deliver the most patient-centered digital clinic that improves member experience and outcomes while reducing costs. wrnch allows us to take a giant leap forward in all respects.”

Dale W Wood Congratulates the Huma Team on Raising $130 Million

Major health and technology companies across the world have committed upwards of $130 million to Huma Therapeutics, the health-tech company backed by Dale Ventures.

Rhaeos Awarded $4 Million NIH SBIR Grant

Under the NIH SBIR grant, Rhaeos will leverage their existing wireless sensor hardware to provide additional quantitative flow data to the clinician, giving insight into this currently inaccessible and highly relevant shunt performance metric.

Gynesonics Announces FDA Clearance of Next Generation Sonata System

“This clearance brings significant system improvements that expand the location of fibroids that can be treated while allowing the physician to control all aspects of the treatment from within the sterile field,” said Jiayu Chen, Ph.D. Vice President, Engineering and Advanced Technologies at Gynesonics.

Blackrock Neurotech Invests In Groundbreaking Auditory Nerve Implant With University Of Minnesota And MED-EL

The new investment will enable the development and translation of a new ANI through preclinical studies and later, a pilot clinical trial, where the ANI is then implanted in up to three deaf patients.

Jonathan Chapman: New President/CEO of Trividia Health

Chapman said, “I’m honored to join the Trividia team as President and CEO. This organization has a long history of leadership within the healthcare industry as a provider of accurate, accessible, and affordable point-of-care solutions for the management of diabetes.”

SOLOPASS® System (Bedside Neuro-Navigation Device) Receives FDA 510(k) Clearance

inTRAvent’s SOLOPASS® system brings simple, portable, bedside neuro-navigation into the intensive care unit.

By using this website you agree to accept Medical Device News Magazine Privacy Policy